Dermatology Doctors in Radnor, PA Accepting Medicare

5 Dermatology doctors found. Showing 1 - 5

Meera Sivendran, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 King Of Prussia Rd, Radnor, PA 19087 Phone: 610-902-2000

Rudolf Roth, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 King Of Prussia Rd, Radnor, PA 19087 Phone: 610-902-2000

Dr. Analisa Vincent Halpern, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 145 King Of Prussia Rd Ste 306, Radnor, PA 19087 Phone: 610-902-2400    Fax: 610-902-2404

Cherie M Ditre, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 King Of Prussia Rd, Radnor, PA 19087 Phone: 610-902-2428    Fax: 610-902-2404

Dr. Catherine M Quirk, MD Dermatology Medicare: Medicare Enrolled Practice Location: 250 King Of Prussia Road, Radnor, PA 19087 Phone: 610-902-2000

News Archive

Study demonstrates rarity of familial hypercholesterolemia mutations in individuals with high cholesterol

Only a small fraction of people with very high cholesterol can attribute their condition to a genetic mutation related to familial hypercholesterolemia, but individuals with these mutations face a high risk of developing early-onset coronary artery disease, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 7 million people in Europe. It is a progressive chronic disease in which episodes become more frequent and long-lasting over time. Conventional anti-arrhythmic therapy aims at halting progression and reducing symptoms, but the use of most anti-arrhythmic drugs is compromised by severe side effects, such as pro-arrhythmia or extra-cardiac organ toxicity.

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive's anti-viral preclinical program, with compound designated NVP018, has generated significant data indicating that NVP018 has the potential to become an effective alternative or addition to current drugs for treating chronic hepatitis B infections.

55% of medical device industry professionals looking for a job change

According to a random online survey of 2,150 medical device industry professionals between January 4 and January 13, a full 55 percent are looking at 2010 as the year to make a job change.

Read more Medical News

› Verified 6 days ago